Gilead Sciences (GILD) stock slips as the company agrees to pay $202M to settle allegations that its HIV drug promotion program violated U.S. law. Read more here.

Massachusetts AG Campbell secures $1.6 million for the state's Medicaid in a settlement with Gilead over illegal kickbacks ...

Gilead Sciences, Inc. was sued for running an illegal kickback scheme to promote its own HIV medications, Attorney General Dave Sunday’s Office announced Tuesday. “Gilead used illegal kickbacks to ...

GSK has expanded its voluntary licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) for cabotegravir, allowing it to be produced by three generic drugmakers and supplied to ...